NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
Kineta Inc.
DualityBio Inc.
Genetron Health
Blue Note Therapeutics
Rigen Biotech
Diaxonhit